We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Constructive Bio plans to reprogramme microbes to make new materials from drugs to biodegradable plastics
Over half of all US adults take them
New York City finds evidence of long-suppressed virus linked to recent samples in UK and Israel
New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice
Climate change effect on ‘earth’s refrigerator’ will have far reaching consequences, scientists say
Move to increase protection against virus comes as sewage surveillance indicates transmission is taking place
NHS warns higher than expected demand leaves it facing acute shortages until shipments in late September
Historic Potala Palace closed as mass testing rolled out in Lhasa to contain Omicron variant
US drugmaker and French partner begin late-stage trial with 14% of global population showing evidence of infection
The Archie Battersbee case shows that some disputes are better settled judicially
Some people are travelling abroad to get vaccinated in wake of severe shortages and increasing case numbers
Decision will allow Biden administration to tap new resources to combat disease amid criticism over its response
House of Lords committee and think-tank separately urge new PM to focus on results and invest more in R&D
Yale research could expand donor organ availability but blurs boundary between life and death
Move follows declarations of emergency by California and Illinois amid growing criticism of US government’s response
Investors warn that lack of availability is driving some companies to US cities
President’s doctor says 79-year-old has ‘rebound’ case of coronavirus but no symptoms
Anglo-Swedish pharmaceutical group wants to capitalise on its $39bn acquisition of Alexion
Scale of NHS treatment disaster implies £400mn bill for those ‘living on borrowed time’
If the funding of small companies is threatened, then vital and transformative research will stop
Although trend in Northern Ireland is ‘uncertain’, latest data suggest virus wave may be in retreat
Injectable cure for congenital cardiomyopathies could be available within a few years, says UK charity
Breakthrough by Alphabet-owned AI company will significantly reduce time required to make biological discoveries
Funding from Coalition for Epidemic Preparedness Innovations to ‘create critical tools’ to assess jabs
P53 is the most studied protein in the human body, but researchers are expanding their horizons
International Edition
